Selegiline enhances survival and neurite outgrowth of MPP+-treated dopaminergic neurons
- 15 November 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 269 (3) , R3-R4
- https://doi.org/10.1016/0922-4106(94)90048-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-Methyl-4-Phenylpyridinium (MPP+)Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- L-Deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brainNeuroReport, 1993
- FGF‐2‐mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: Specificity and impact of culture conditions, non‐dopaminergic neurons, and astroglial cellsJournal of Neuroscience Research, 1993
- Selegiline can mediate neuronal rescue rather than neuronal protectionMovement Disorders, 1993
- Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP+-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGFBrain Research, 1992
- Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐DeprenylJournal of Neurochemistry, 1986
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984